Skip to content

Clinical trials

Hepatitis B, Chronic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Country / region: Germany Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20053
20063
20072
20083
20093
20102
20116
20122
20131
20143
20151
20182
20193
20204
20211
20226
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated6
Unknown status4
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences8
GlaxoSmithKline6
Hoffmann-La Roche6
Bristol-Myers Squibb5
Novartis Pharmaceuticals5
Janssen Sciences Ireland UC3
Hannover Medical School2
Janssen Research & Development, LLC2
Johann Wolfgang Goethe University Hospital2
Transgene2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic52
Hepatitis B12
Hepatitis6
Hepatitis, Chronic2
Acquired Immunodeficiency Syndrome1
Fibrosis1
HIV Infections1
HIV Seropositivity1
Liver Cirrhosis1

Trials

Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.